Protalix BioTherapeutics, Inc. (PLX) — EPS (Diluted)
| Fiscal Year | EPS (Diluted) | Change YoY |
|---|---|---|
| 2025 | $-0.08 | -300.0% |
| 2024 | $0.04 | -55.6% |
| 2023 | $0.09 | +129.0% |
| 2022 | $-0.31 | +50.0% |
| 2021 | $-0.62 | -181.8% |
| 2020 | $-0.22 | +82.1% |
| 2019 | $-1.23 | — |
| Fiscal Year | EPS (Diluted) | Change YoY |
|---|---|---|
| 2025 | $-0.08 | -300.0% |
| 2024 | $0.04 | -55.6% |
| 2023 | $0.09 | +129.0% |
| 2022 | $-0.31 | +50.0% |
| 2021 | $-0.62 | -181.8% |
| 2020 | $-0.22 | +82.1% |
| 2019 | $-1.23 | — |